Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,115.70
-7.30 (-0.65%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,838,399
Open
1,129.40
Bid (Size)
1,116.00 (40)
Ask (Size)
1,116.29 (40)
Prev. Close
1,123.00
Today's Range
1,113.29 - 1,131.44
52wk Range
712.05 - 1,292.65
Shares Outstanding
956,580,893
Dividend Yield
0.62%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
↗
September 11, 2026
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
Via
The Motley Fool
Topics
ETFs
Could This New Opportunity Be Worth Billions for Novo Nordisk?
↗
September 11, 2026
The worst may be in the rearview mirror for the drugmaker.
Via
The Motley Fool
Performance
YTD
+3.3%
+3.3%
1 Month
-8.6%
-8.6%
3 Month
-1.5%
-1.5%
6 Month
+13.3%
+13.3%
1 Year
+47.5%
+47.5%
More News
Read More
Amgen Drops 10% on a Trial It Didn't Even Run
↗
September 11, 2026
Via
MarketBeat
Eli Lilly (NYSE:LLY) Combines Strong Growth With a Quality Technical Setup
↗
September 11, 2026
Via
Chartmill
Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health Initiatives: Report
↗
September 11, 2026
Via
Benzinga
These 5 ETFs Are Built for Bear Markets. History Says Now Is a Fantastic Time to Buy.
↗
September 10, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
↗
September 10, 2026
Via
The Motley Fool
Topics
ETFs
VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials
September 10, 2026
Via
AB Newswire
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?
↗
September 10, 2026
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
↗
September 10, 2026
Via
The Motley Fool
Topics
ETFs
Analysts Have a $92 Target on Viking Therapeutics. Here's What Has to Go Right to Get There.
↗
September 10, 2026
Via
The Motley Fool
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom
↗
September 10, 2026
Via
MarketBeat
Topics
Earnings
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?
↗
September 09, 2026
Via
The Motley Fool
Topics
ETFs
2025 R&D Spending And Intensity Benchmarks
September 09, 2026
Via
PRLog
Topics
Supply Chain
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031
↗
September 09, 2026
Via
The Motley Fool
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
↗
September 08, 2026
Via
Benzinga
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?
↗
September 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever
↗
September 08, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back
↗
September 08, 2026
Via
Benzinga
Topics
ETFs
Why Is Eli Lilly Stock Falling Tuesday?
↗
September 08, 2026
Via
Benzinga
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma
↗
September 08, 2026
Via
Investor's Business Daily
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?
↗
September 07, 2026
Via
The Motley Fool
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
↗
September 06, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Bonds
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock
↗
September 06, 2026
Via
The Motley Fool
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
↗
September 05, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,115.70
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 09/11/26 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,067.26B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,067B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.